MSB 2.70% 95.0¢ mesoblast limited

Ann: Mesoblast Update on COVID-19 ARDS Trial, page-421

  1. 30,340 Posts.
    lightbulb Created with Sketch. 1837
    it works either the trial

    cannot recruit because nobody is not taking pharmaceutical drugs and therefore doesn't qualify
    OR
    can't prove it was MSB's MSCs that caused the survival

    Delays and obstruction have caused this. MSB was ready to go early on and the FDA frrted around until the other drugs got emergency approvals.

    This is why I have been banging on about governance at the FDA.

    Also the brokers who are connected with the US got the heads-up and have been signalling ahead of this moves. They did the same thing with the Nasdaq listing and that was a bloodbath too.

    Then miraculously, they or their mates get over the 5% and have to disclose a major holding.
    Can't be helped I guess....<sarcasm>


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
0.025(2.70%)
Mkt cap ! $1.084B
Open High Low Value Volume
94.0¢ 96.8¢ 93.5¢ $4.207M 4.417M

Buyers (Bids)

No. Vol. Price($)
3 42268 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.0¢ 48002 3
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.